# Corrigendum: FXYD5/Dysadherin, a biomarker of endometrial cancer myometrial invasion and aggressiveness: its relationship with TGF-β1 and NF-κB pathways

**Authors:** María José Besso, Marina Rosso, Lara Lapyckyj, Cristian Pablo Moiola, María Laura Matos, María Florencia Mercogliano, Roxana Schillaci, Jaume Reventos, Eva Colas, Antonio Gil-Moreno, Alejandra Wernicke, Roberto Orti, Mónica Hebe Vazquez-Levin

PMC · DOI: 10.3389/fonc.2023.1322204 · 2024-01-23

## Full-text entities

- **Genes:** TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, FXYD5 (FXYD domain containing ion transport regulator 5) [NCBI Gene 53827] {aka DYSAD, HSPC113, IWU1, KCT1, OIT2, PRO6241}
- **Diseases:** endometrial cancer (MESH:D016889)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10844545/full.md

---
Source: https://tomesphere.com/paper/PMC10844545